Dear Colleagues,

This special issue explores the transformative role of artificial intelligence (AI) in personalized medicine. Integrating AI tools enables clinicians to analyze complex data from pharmacogenomics to predict patient-specific drug responses, providing customized therapeutic interventions. The combination of these fields, supported by AI, promises to revolutionize clinical decision-making and foster more individualized approaches to healthcare, thereby improving patient outcomes. This issue aims to explore innovative approaches and advances in the field of personalized medicine, emphasizing the integration of diagnostic and therapeutic strategies tailored to individual patient needs.

Potential topics of interest include, but are not limited to, the following:

• Personalized Diagnostics: Development and application of diagnostic tools that cater to individual patient profiles.
• Therapeutic Interventions: Innovative treatment modalities that are customized based on genetic, environmental, and lifestyle factors.
• Technology Integration: Use of artificial intelligence and machine learning in personalizing diagnostics and therapies.
• Patient-Centred Approaches: Strategies to involve patients in their own care plans through shared decision making.
• Outcome Measurement: Evaluation of the effectiveness of personalized interventions compared to traditional methods.

We look forward to your contributions that will advance the discourse on personalized diagnostic and therapeutic interventions.

Prof Dr. Chi-Chang Chang

Prof. Dr. Ahmet Altun

Guest Editors

Keywords: Artificial Intelligence; Personalized Medicine; Pharmacology; Molecular Biology; Histopathology; Drug Discovery; Diagnostics